ArticleFrontiers in oncology2021

Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models.

Qianwen Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.